The Royal Pharmaceutical Society has launched a set of briefings describing how you can encourage patients with specific conditions to get the most out of their medicines. Here, you can find articles describing the briefings and everything else The Pharmaceutical Journal has to offer about Medicines optimisation.
Helping patients to make sense of a serious and complex long-term condition is the most interesting part of my role, says Rocco Hadland.
A pilot study has found that medicines optimisation by community pharmacists has the potential to save clinical commissioning groups (CCGs) thousands of pounds.
The 100,000 Genome Project is driving the move from a ‘one size fits all’ approach to treatment, towards personalised, or precision, medicine. Genetic information is also being used by pharmaceutical companies to help speed up drug discovery and development, and reduce the associated costs. Pharmacists will have an important role to play when genomic medicine goes mainstream.
The opportunities for pharmacists within the community services sector are huge, says James Andrews.
Community pharmacists are well placed to assist in the early identification of dementia, as well as to help patients to manage their medicines. However, a wider role for pharmacists, for example, conducting medicines reviews in patients’ homes, will depend on how their clinical role develops.
Science of sunscreenSubscription
Sun exposure is the primary cause of skin cancer. According to Cancer Research UK, more than 8 in 10 cases of melanoma could be prevented through better knowledge of sun damage and how to protect against it.
Viv Horton explains how her hospital set up a Parkinson’s advanced symptom unit to provide holistic care for patients with Parkinson’s disease.
Depression in adults: recognition and managementSubscription
Pharmacists and healthcare professionals should be able to recognise the symptoms of depression in people who use their services and direct them towards accessing treatment. This article examines how a diagnosis of depression is made, the pharmacological and non-pharmacological treatments available, specific considerations for different patient groups, self-management approaches, and the role of the pharmacy team in managing and supporting patients who have symptoms of depression.
Genotype-guided dosing improves safety of warfarin Subscription
Community pharmacist: the primary care expertsSubscription
Devising ways to improve medicines adherenceSubscription
Improving the use of medicines in East CheshireSubscription
Launch of Prescribing Awareness Week initiativeSubscription